S&P 500   3,766.75 (+2.40%)
DOW   30,129.15 (+2.16%)
QQQ   280.14 (+2.42%)
AAPL   144.85 (+1.68%)
MSFT   247.47 (+2.80%)
META   140.02 (+1.02%)
GOOGL   101.09 (+2.48%)
AMZN   120.99 (+4.41%)
TSLA   244.93 (+1.04%)
NVDA   129.98 (+3.88%)
NIO   16.58 (+7.04%)
BABA   83.67 (+4.00%)
AMD   67.57 (+2.21%)
T   16.00 (+0.63%)
MU   54.04 (+4.49%)
CGC   3.11 (+6.87%)
F   12.21 (+6.45%)
GE   66.62 (+4.75%)
DIS   100.57 (+3.54%)
AMC   7.52 (+9.30%)
PYPL   91.77 (+5.26%)
PFE   44.29 (+0.34%)
NFLX   238.01 (-0.43%)
S&P 500   3,766.75 (+2.40%)
DOW   30,129.15 (+2.16%)
QQQ   280.14 (+2.42%)
AAPL   144.85 (+1.68%)
MSFT   247.47 (+2.80%)
META   140.02 (+1.02%)
GOOGL   101.09 (+2.48%)
AMZN   120.99 (+4.41%)
TSLA   244.93 (+1.04%)
NVDA   129.98 (+3.88%)
NIO   16.58 (+7.04%)
BABA   83.67 (+4.00%)
AMD   67.57 (+2.21%)
T   16.00 (+0.63%)
MU   54.04 (+4.49%)
CGC   3.11 (+6.87%)
F   12.21 (+6.45%)
GE   66.62 (+4.75%)
DIS   100.57 (+3.54%)
AMC   7.52 (+9.30%)
PYPL   91.77 (+5.26%)
PFE   44.29 (+0.34%)
NFLX   238.01 (-0.43%)
S&P 500   3,766.75 (+2.40%)
DOW   30,129.15 (+2.16%)
QQQ   280.14 (+2.42%)
AAPL   144.85 (+1.68%)
MSFT   247.47 (+2.80%)
META   140.02 (+1.02%)
GOOGL   101.09 (+2.48%)
AMZN   120.99 (+4.41%)
TSLA   244.93 (+1.04%)
NVDA   129.98 (+3.88%)
NIO   16.58 (+7.04%)
BABA   83.67 (+4.00%)
AMD   67.57 (+2.21%)
T   16.00 (+0.63%)
MU   54.04 (+4.49%)
CGC   3.11 (+6.87%)
F   12.21 (+6.45%)
GE   66.62 (+4.75%)
DIS   100.57 (+3.54%)
AMC   7.52 (+9.30%)
PYPL   91.77 (+5.26%)
PFE   44.29 (+0.34%)
NFLX   238.01 (-0.43%)
S&P 500   3,766.75 (+2.40%)
DOW   30,129.15 (+2.16%)
QQQ   280.14 (+2.42%)
AAPL   144.85 (+1.68%)
MSFT   247.47 (+2.80%)
META   140.02 (+1.02%)
GOOGL   101.09 (+2.48%)
AMZN   120.99 (+4.41%)
TSLA   244.93 (+1.04%)
NVDA   129.98 (+3.88%)
NIO   16.58 (+7.04%)
BABA   83.67 (+4.00%)
AMD   67.57 (+2.21%)
T   16.00 (+0.63%)
MU   54.04 (+4.49%)
CGC   3.11 (+6.87%)
F   12.21 (+6.45%)
GE   66.62 (+4.75%)
DIS   100.57 (+3.54%)
AMC   7.52 (+9.30%)
PYPL   91.77 (+5.26%)
PFE   44.29 (+0.34%)
NFLX   238.01 (-0.43%)
NASDAQ:CPRX

Catalyst Pharmaceuticals - CPRX SEC Filings & 10K Form

$12.77
-0.37 (-2.82%)
(As of 10/4/2022 01:35 PM ET)
Add
Compare
Today's Range
$12.71
$13.40
50-Day Range
$10.00
$15.52
52-Week Range
$5.14
$17.22
Volume
37,908 shs
Average Volume
5.45 million shs
Market Capitalization
$1.31 billion
P/E Ratio
25.04
Dividend Yield
N/A
Price Target
$14.81

Recent Catalyst Pharmaceuticals SEC Filings

DateFilerForm TypeView
09/29/2022
3:30 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2022
4:01 PM
Catalyst Pharmaceuticals (Issuer)
GRANDE ALICIA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2022
4:28 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/15/2022
4:02 PM
Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2022
4:01 PM
Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2022
4:01 PM
Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2022
4:00 PM
Catalyst Pharmaceuticals (Issuer)
COELHO PHILIP H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2022
3:30 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/07/2022
10:35 AM
Catalyst Pharmaceuticals (Filer)
Form DEFA14A
08/30/2022
4:00 PM
Catalyst Pharmaceuticals (Issuer)
GRANDE ALICIA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2022
4:01 PM
Catalyst Pharmaceuticals (Issuer)
Daly Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2022
4:01 PM
Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2022
4:00 PM
Catalyst Pharmaceuticals (Issuer)
Del Carmen Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2022
4:03 PM
Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2022
4:03 PM
Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2022
4:02 PM
Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2022
4:02 PM
Catalyst Pharmaceuticals (Issuer)
GRANDE ALICIA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2022
4:02 PM
Catalyst Pharmaceuticals (Issuer)
COELHO PHILIP H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2022
4:11 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2022
3:30 PM
Catalyst Pharmaceuticals (Filer)
Form DEF 14A
07/12/2022
7:30 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2022
7:30 AM
Catalyst Pharmaceuticals (Filer)
Catalyst Pharmaceuticals (Filer)
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2022
4:00 PM
Catalyst Pharmaceuticals (Issuer)
Del Carmen Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2022
4:02 PM
Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2022
3:31 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2022
3:07 PM
Catalyst Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/19/2021
4:07 PM
Catalyst Pharmaceuticals (Issuer)
GRANDE ALICIA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2021
4:28 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2021
3:34 PM
Catalyst Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/06/2021
7:15 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/29/2021
7:22 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2021
3:25 PM
Catalyst Pharmaceuticals (Issuer)
Del Carmen Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2021
4:06 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2021
4:23 PM
Catalyst Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2021
3:31 PM
Catalyst Pharmaceuticals (Filer)
Form 10-K/A
03/22/2021
7:35 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/16/2021
7:11 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2021
4:17 PM
Catalyst Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/16/2021
1:59 PM
ARMISTICE CAPITAL, LLC (Filed by)
Catalyst Pharmaceuticals (Subject)
Form SC 13G/A
02/05/2021
11:32 AM
Catalyst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
01/04/2021
3:42 PM
Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
3:40 PM
Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
3:39 PM
Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
3:38 PM
Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
3:37 PM
Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
3:36 PM
Catalyst Pharmaceuticals (Issuer)
GRANDE ALICIA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
3:35 PM
Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
3:34 PM
Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
3:33 PM
Catalyst Pharmaceuticals (Issuer)
Del Carmen Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
3:32 PM
Catalyst Pharmaceuticals (Issuer)
Daly Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
3:30 PM
Catalyst Pharmaceuticals (Issuer)
COELHO PHILIP H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2020
3:47 PM
Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2020
3:43 PM
Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2020
3:37 PM
Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2020
3:35 PM
Catalyst Pharmaceuticals (Issuer)
Daly Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2020
6:26 PM
Catalyst Pharmaceuticals (Issuer)
GRANDE ALICIA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2020
6:25 PM
Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2020
5:56 PM
Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2020
5:15 PM
Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2020
4:40 PM
Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2020
4:34 PM
Catalyst Pharmaceuticals (Issuer)
COELHO PHILIP H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2020
4:09 PM
Catalyst Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/19/2020
7:04 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2020
4:26 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2020
1:23 PM
Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2020
9:55 AM
Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2020
4:00 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2020
4:15 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2020
3:46 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2020
4:17 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2020
3:06 PM
Catalyst Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2020
11:15 PM
Catalyst Pharmaceuticals (Filer)
Form EFFECT
07/23/2020
4:01 PM
Catalyst Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/07/2020
3:30 PM
Catalyst Pharmaceuticals (Filer)
Form DEF 14A
06/26/2020
3:06 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2020
4:13 PM
Catalyst Pharmaceuticals (Filer)
Form PRE 14A
05/13/2020
3:30 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2020
4:21 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2020
7:09 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2020
3:39 PM
ARMISTICE CAPITAL, LLC (Filed by)
Catalyst Pharmaceuticals (Subject)
Form SC 13G
03/16/2020
4:24 PM
Catalyst Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/13/2020
4:19 PM
Broadfin Capital, LLC (Filed by)
Catalyst Pharmaceuticals (Subject)
Form SC 13G/A
02/05/2020
7:00 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2020
3:59 PM
Catalyst Pharmaceuticals (Subject)
Consonance Capital Management LP (Filed by)
Form SC 13G/A
01/06/2020
7:55 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2019
3:37 PM
Catalyst Pharmaceuticals (Subject)
Consonance Capital Management LP (Filed by)
Form SC 13G/A
12/06/2019
3:52 PM
Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
4:29 PM
Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
4:27 PM
Catalyst Pharmaceuticals (Issuer)
Daly Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
4:26 PM
Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
4:25 PM
Catalyst Pharmaceuticals (Issuer)
COELHO PHILIP H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
4:24 PM
Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
4:23 PM
Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
4:21 PM
Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
4:20 PM
Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
4:19 PM
BRENNAN DANIEL (Reporting)
Catalyst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
4:18 PM
Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
4:16 PM
Catalyst Pharmaceuticals (Issuer)
GRANDE ALICIA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2019
4:02 PM
Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2019
3:23 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page (NASDAQ:CPRX) was last updated on 10/4/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.